Awa, Edilberto E.
HRN: 26-61-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/28/2025
02/04/2025
IV
4.5
Q8
Sepsis
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes